News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ecopia BioSciences Inc. (EIA.TO)'s Phase I Dose-Escalation Portion Successfully Completed



1/11/2007 3:19:58 PM

MONTREAL, QUEBEC -- (MARKET WIRE) -- January 11, 2007 -- Ecopia BioSciences Inc. (TSX: EIA) is pleased to announce the successful completion of the first portion, dose-escalation, of its Phase I clinical trial for ECO-4601, the Company's lead anticancer drug candidate. The completion of this milestone allows Ecopia to initiate the second portion of its clinical trial, the extension Phase.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES